QuantRx Biomedical to acquire NuRx Pharmaceuticals - MarketLine Financial Deals

QuantRx Biomedical to acquire NuRx Pharmaceuticals

QuantRx Biomedical to acquire NuRx Pharmaceuticals - MarketLine Financial Deals
QuantRx Biomedical to acquire NuRx Pharmaceuticals
Published Jan 29, 2010
2 pages — Published Jan 29, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

QuantRx Biomedical Corporation has agreed to acquire NuRx Pharmaceuticals, Inc., a biopharmaceutical company focused on oncology, in an all stock and tax-free transaction.

  
Source:
Document ID
MA18364_100202
Country
Ticker
QTXB=US
Ticker
NUXP=US
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "QuantRx Biomedical to acquire NuRx Pharmaceuticals" Jan 29, 2010. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/QuantRx-Biomedical-to-acquire-NuRx-Pharmaceuticals-2052-23039>
  
APA:
MarketLine Financial Deals. (2010). QuantRx Biomedical to acquire NuRx Pharmaceuticals Jan 29, 2010. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/QuantRx-Biomedical-to-acquire-NuRx-Pharmaceuticals-2052-23039>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.